Annual Shareholders Equity
-$455.53 M
-$160.93 M-54.63%
31 December 2023
Summary:
BioCryst Pharmaceuticals annual stockholders equity is currently -$455.53 million, with the most recent change of -$160.93 million (-54.63%) on 31 December 2023. During the last 3 years, it has fallen by -$436.27 million (-2264.90%). BCRX annual shareholders equity is now -628.05% below its all-time high of $86.27 million, reached on 31 December 2009.BCRX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
-$468.56 M
+$7.04 M+1.48%
30 September 2024
Summary:
BioCryst Pharmaceuticals quarterly stockholders equity is currently -$468.56 million, with the most recent change of +$7.04 million (+1.48%) on 30 September 2024. Over the past year, it has dropped by -$57.58 million (-14.01%). BCRX quarterly shareholders equity is now -565.62% below its all-time high of $100.63 million, reached on 30 September 2017.BCRX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCRX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -54.6% | -14.0% |
| 3 y3 years | -2264.9% | -218.7% |
| 5 y5 years | -1025.2% | -1035.8% |
BCRX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -2264.9% | at low | -338.0% | +1.6% |
| 5 y | 5 years | -1025.2% | at low | -712.4% | +1.6% |
| alltime | all time | -628.0% | at low | -565.6% | +1.6% |
BioCryst Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$468.56 M(-1.5%) |
| June 2024 | - | -$475.61 M(-0.1%) |
| Mar 2024 | - | -$476.17 M(+4.5%) |
| Dec 2023 | -$455.53 M(+54.6%) | -$455.53 M(+10.8%) |
| Sept 2023 | - | -$410.99 M(+5.7%) |
| June 2023 | - | -$388.71 M(+18.4%) |
| Mar 2023 | - | -$328.29 M(+11.4%) |
| Dec 2022 | -$294.60 M(+175.4%) | -$294.60 M(+21.4%) |
| Sept 2022 | - | -$242.66 M(+13.8%) |
| June 2022 | - | -$213.23 M(+29.8%) |
| Mar 2022 | - | -$164.22 M(+53.5%) |
| Dec 2021 | -$106.99 M(+455.4%) | -$106.99 M(-27.2%) |
| Sept 2021 | - | -$147.04 M(+38.6%) |
| June 2021 | - | -$106.08 M(+41.5%) |
| Mar 2021 | - | -$74.99 M(+289.3%) |
| Dec 2020 | -$19.26 M(-150.4%) | -$19.26 M(-157.3%) |
| Sept 2020 | - | $33.64 M(-56.0%) |
| June 2020 | - | $76.51 M(+1997.2%) |
| Mar 2020 | - | $3.65 M(-90.5%) |
| Dec 2019 | $38.25 M(-22.3%) | $38.25 M(-192.7%) |
| Sept 2019 | - | -$41.25 M(+348.7%) |
| June 2019 | - | -$9.19 M(-140.8%) |
| Mar 2019 | - | $22.51 M(-54.3%) |
| Dec 2018 | $49.23 M(-41.2%) | $49.23 M(-32.4%) |
| Sept 2018 | - | $72.87 M(+57.8%) |
| June 2018 | - | $46.18 M(-25.6%) |
| Mar 2018 | - | $62.05 M(-25.9%) |
| Dec 2017 | $83.77 M(+5208.4%) | $83.77 M(-16.8%) |
| Sept 2017 | - | $100.63 M(+318.0%) |
| June 2017 | - | $24.08 M(-37.5%) |
| Mar 2017 | - | $38.53 M(+2341.7%) |
| Dec 2016 | $1.58 M(-96.7%) | $1.58 M(-60.5%) |
| Sept 2016 | - | $3.99 M(-70.2%) |
| June 2016 | - | $13.39 M(-51.8%) |
| Mar 2016 | - | $27.80 M(-41.8%) |
| Dec 2015 | $47.72 M(-36.9%) | $47.72 M(-25.5%) |
| Sept 2015 | - | $64.05 M(-15.8%) |
| June 2015 | - | $76.09 M(+18.2%) |
| Mar 2015 | - | $64.37 M(-14.9%) |
| Dec 2014 | $75.64 M(-6817.1%) | $75.64 M(-9.4%) |
| Sept 2014 | - | $83.45 M(-7.4%) |
| June 2014 | - | $90.09 M(-1674.2%) |
| Mar 2014 | - | -$5.72 M(+408.3%) |
| Dec 2013 | -$1.13 M(+148.0%) | -$1.13 M(-133.0%) |
| Sept 2013 | - | $3.41 M(-137.7%) |
| June 2013 | - | -$9.05 M(+218.6%) |
| Mar 2013 | - | -$2.84 M(+525.6%) |
| Dec 2012 | -$454.00 K(-103.1%) | -$454.00 K(-104.6%) |
| Sept 2012 | - | $9.78 M(-37.5%) |
| June 2012 | - | $15.66 M(-32.4%) |
| Mar 2012 | - | $23.15 M(+56.4%) |
| Dec 2011 | $14.81 M(-77.4%) | $14.81 M(-43.1%) |
| Sept 2011 | - | $26.04 M(-33.7%) |
| June 2011 | - | $39.27 M(-27.5%) |
| Mar 2011 | - | $54.17 M(-17.3%) |
| Dec 2010 | $65.50 M(-24.1%) | $65.50 M(-11.9%) |
| Sept 2010 | - | $74.35 M(-11.1%) |
| June 2010 | - | $83.61 M(-2.2%) |
| Mar 2010 | - | $85.53 M(-0.9%) |
| Dec 2009 | $86.27 M | $86.27 M(+266.4%) |
| Sept 2009 | - | $23.55 M(-24.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | $31.29 M(-18.8%) |
| Mar 2009 | - | $38.52 M(-17.0%) |
| Dec 2008 | $46.43 M(-28.5%) | $46.43 M(+32.6%) |
| Sept 2008 | - | $35.01 M(-17.5%) |
| June 2008 | - | $42.42 M(-21.8%) |
| Mar 2008 | - | $54.22 M(-16.5%) |
| Dec 2007 | $64.91 M(+206.8%) | $64.91 M(-1.1%) |
| Sept 2007 | - | $65.61 M(+602.2%) |
| June 2007 | - | $9.34 M(-33.2%) |
| Mar 2007 | - | $13.99 M(-33.9%) |
| Dec 2006 | $21.16 M(-63.8%) | $21.16 M(-29.5%) |
| Sept 2006 | - | $30.02 M(-32.4%) |
| June 2006 | - | $44.39 M(-16.6%) |
| Mar 2006 | - | $53.22 M(-8.9%) |
| Dec 2005 | $58.44 M(+99.2%) | $58.44 M(+69.9%) |
| Sept 2005 | - | $34.41 M(-15.8%) |
| June 2005 | - | $40.86 M(-12.1%) |
| Mar 2005 | - | $46.51 M(+58.5%) |
| Dec 2004 | $29.33 M(+3.1%) | $29.33 M(-14.5%) |
| Sept 2004 | - | $34.32 M(-12.9%) |
| June 2004 | - | $39.41 M(-9.3%) |
| Mar 2004 | - | $43.43 M(+52.7%) |
| Dec 2003 | $28.45 M(-29.1%) | $28.45 M(-7.7%) |
| Sept 2003 | - | $30.81 M(-9.8%) |
| June 2003 | - | $34.16 M(-8.6%) |
| Mar 2003 | - | $37.38 M(-6.9%) |
| Dec 2002 | $40.13 M(-29.4%) | $40.13 M(-6.4%) |
| Sept 2002 | - | $42.86 M(-7.3%) |
| June 2002 | - | $46.21 M(-10.0%) |
| Mar 2002 | - | $51.34 M(-9.6%) |
| Dec 2001 | $56.81 M(-7.6%) | $56.81 M(-8.0%) |
| Sept 2001 | - | $61.75 M(+1.0%) |
| June 2001 | - | $61.15 M(+1.7%) |
| Mar 2001 | - | $60.15 M(-2.2%) |
| Dec 2000 | $61.48 M(-13.9%) | $61.48 M(-13.6%) |
| Sept 2000 | - | $71.14 M(-1.9%) |
| June 2000 | - | $72.56 M(-2.2%) |
| Mar 2000 | - | $74.22 M(+4.0%) |
| Dec 1999 | $71.40 M(+157.8%) | $71.40 M(+186.7%) |
| Sept 1999 | - | $24.90 M(-1.2%) |
| June 1999 | - | $25.20 M(-0.8%) |
| Mar 1999 | - | $25.40 M(-8.3%) |
| Dec 1998 | $27.70 M(+9.5%) | $27.70 M(+22.0%) |
| Sept 1998 | - | $22.70 M(+14.6%) |
| June 1998 | - | $19.80 M(-13.2%) |
| Mar 1998 | - | $22.80 M(-9.9%) |
| Dec 1997 | $25.30 M(-28.5%) | $25.30 M(-10.0%) |
| Sept 1997 | - | $28.10 M(-7.9%) |
| June 1997 | - | $30.50 M(-6.2%) |
| Mar 1997 | - | $32.50 M(-8.2%) |
| Dec 1996 | $35.40 M(+213.3%) | $35.40 M(+4.7%) |
| Sept 1996 | - | $33.80 M(+89.9%) |
| June 1996 | - | $17.80 M(+1.7%) |
| Mar 1996 | - | $17.50 M(+54.9%) |
| Dec 1995 | $11.30 M(+0.9%) | $11.30 M(-16.3%) |
| Sept 1995 | - | $13.50 M(-11.8%) |
| June 1995 | - | $15.30 M(+84.3%) |
| Mar 1995 | - | $8.30 M(-25.9%) |
| Dec 1994 | $11.20 M | $11.20 M(-13.8%) |
| Sept 1994 | - | $13.00 M(+2.4%) |
| June 1994 | - | $12.70 M(-13.0%) |
| Mar 1994 | - | $14.60 M |
FAQ
- What is BioCryst Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual shareholders equity year-on-year change?
- What is BioCryst Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly shareholders equity year-on-year change?
What is BioCryst Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of BCRX is -$455.53 M
What is the all time high annual shareholders equity for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual stockholders equity is $86.27 M
What is BioCryst Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, BCRX annual stockholders equity has changed by -$160.93 M (-54.63%)
What is BioCryst Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of BCRX is -$468.56 M
What is the all time high quarterly shareholders equity for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly stockholders equity is $100.63 M
What is BioCryst Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, BCRX quarterly stockholders equity has changed by -$57.58 M (-14.01%)